OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
14
Results
Show all
Save search
Copy query
Show results for
Unknown
(11)
Proteomics
(3)
Organisms
Homo sapiens
(3)
Repository
iProX
(3)
Publication Date
2023
(2)
2025
(1)
Release Date
2024
(4)
2025
(2)
2023
(2)
2021
(1)
2017
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Crystal structure of bis-(1,10-phenanthroline-κ
2
N
,
N
')(1,3-thia-zole-2-thiol-ato-κ
2
S
2
,
N
)nickel(II) hexa-fluorido-phosphate 1,4-dioxane sesquisolvate.
Not available
S-EPMC5382628
|
biostudies-literature
Cite
Rare penetrant mutations confer severe risk of common diseases.
Not available
S-EPMC10187340
|
biostudies-literature
Cite
Proteomic and phospho-proteomic raw data of Wilms tumor tissue and normal adjacent kidney tissue.
Proteomic and phospho-proteomic raw data of Wilms tumor tissue and normal adjacent kidney tissue from Wilms tumor patients.
ORGANISM(S):
Homo Sapiens
2025-04-30
|
PXD063650
|
Cite
Gel-based LC-MSMS, the interactome of XAF1 in 293T cells
We utilized mass spectrometry to analyze the interacting proteins of XAF1 in 293T cells.
ORGANISM(S):
Homo Sapiens
2023-03-22
|
PXD041021
|
Cite
Gel-based LC-MSMS, the interactome of RNF114 in 293T cells
We utilized mass spectrometry to analyze the interactome of RNF114 in 293T cells.
ORGANISM(S):
Homo Sapiens
2023-08-07
|
PXD044440
|
Cite
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.
Not available
S-EPMC4057242
|
biostudies-literature
Cite
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867
|
biostudies-literature
Cite
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7616743
|
biostudies-literature
Cite
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591
|
biostudies-literature
Cite
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Not available
S-EPMC7618536
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets